Purpose The response definitions proposed from the European LeukemiaNet (ELN) are described based on imatinib front-line therapy. insufficient efficacy, development to accelerated or blastic stages, or death anytime. Results General, 155 sufferers (93%) achieved full cytogenetic response (CCyR), including 146…